ONCOLife presents an exclusive interview with Dr. Miguel-Angel Perales, Co-Chair of the CAR T Vision initiative, as he shares ...

We’re honored to share our exclusive interview with Lorna Warick, CEO of Lymphoma Coalition. In this session, we explore the ...

About ONCOLife ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ...

Health and Pharma is a pioneering news and communications platform focused on health science, biotechnology, and pharmaceutical developments.

ONCOLife presents an exclusive interview with Nick Slack, Chairman and CEO of The START Center for Cancer Research. In this session, we explore how the integration of the Carolina Urologic Research ...

South Rampart Pharma has announced promising results from its Phase 1 clinical trials for SRP-001, a non-opioid and non-hepatotoxic small molecule pain relief medication. Published in Scientific ...

Oncolytic viruses are emerging as a promising development in cancer treatment, not only destroying cancer cells but also modulating the tumor microenvironment to enhance immune responses. We had an ...

We are pleased to present an exclusive interview with Dana Brown, CEO and Chairman of the Board at iCAD Inc., to explore the future of breast cancer screening and the role of artificial intelligence ...

Durvalumab, a PD-L1 immune checkpoint inhibitor, works by blocking the interaction between PD-L1 and immune-inhibitory proteins PD-1 and CD80, thereby lifting the brakes on the immune system’s ...